Plasticell delivers stem cell differentiation protocols to Stemnion

11 August 2011

Plasticell has announced the successful completion of a collaboration with Stemnion, Inc. Plasticell used its flagship technology CombiCult to discover multiple novel, serum-free protocols that direct the differentiation of Stemnion’s human placenta-derived stem cells into hard-to-obtain lineages.

The protocols were ranked using Plasticell’s Ariadne bioinformatics software and subsequently validated by Stemnion scientists.

“Using CombiCult's combinatorial technology, we identified several differentiation protocols for our cells at a fraction of the time, resources and cost compared to conventional trial-and-error methods,” said Randall Rupp, Vice-President, Manufacturing and Development, Stemnion, Inc.

“This project once again demonstrates the flexibility and the power of CombiCult to push the differentiation of adult stem cells into various lineages,” said Dr. Lilian Hook, Director of Research at Plasticell. “Stemnion provided us with a challenge that is typical of adult stem cell R&D programmes, however this project was particularly interesting on several fronts, including, for the first time, utilising placenta-derived stem cells as the starting cell-type.”